| Date Field | Doc. No. | Description (Pages) |
|---|
| Jul 1, 2025 | 8 | PROPOSED CONSENT JUDGMENT by Merck Sharp & Dohme LLC. (Joyce, Alexandra) (Entered: 07/01/2025) (3) |
| Jul 1, 2025 | 9 | CONSENT JUDGMENT (CASE CLOSED). Signed by Judge Colm F. Connolly on 7/1/2025. (mws) (Entered: 07/01/2025) (3) |
| Jul 1, 2025 | 10 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (Attachments: # 1 Consent Judgment)(mws) (Entered: 07/01/2025) (0) |
| Apr 16, 2025 | N/A | Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (alb) (Entered: 04/16/2025) (0) |
| Apr 16, 2025 | 7 | STANDING ORDER REGARDING BRIEFING IN ALL CASES (mws) (Entered: 04/16/2025) (2) |
| Apr 11, 2025 | 1 | COMPLAINT against Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. (Filing fee $ 405, receipt number ADEDC-4660319) - filed by Merck Sharp & Dohme LLC. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(oam) (Entered: 04/11/2025) (0) |
| Apr 11, 2025 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) (Entered: 04/11/2025) (3) |
| Apr 11, 2025 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/25/2025. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 8/25/2027. (oam) (Entered: 04/11/2025) (2) |
| Apr 11, 2025 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (oam) (Entered: 04/11/2025) (1) |
| Apr 11, 2025 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme LLC filed by Merck Sharp & Dohme LLC. (oam) (Entered: 04/11/2025) (1) |
| Apr 11, 2025 | 6 | Summons Issued as to Aurobindo Pharma Limited on 4/11/2025; Aurobindo Pharma USA, Inc. on 4/11/2025. (Attachments: # 1 Summons Issued)(oam) (Entered: 04/11/2025) (0) |